BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 36264161)

  • 1. An Aged/Autoimmune B-cell Program Defines the Early Transformation of Extranodal Lymphomas.
    Venturutti L; Rivas MA; Pelzer BW; Flümann R; Hansen J; Karagiannidis I; Xia M; McNally DR; Isshiki Y; Lytle A; Teater M; Chin CR; Meydan C; Knittel G; Ricker E; Mason CE; Ye X; Pan-Hammarström Q; Steidl C; Scott DW; Reinhardt HC; Pernis AB; Béguelin W; Melnick AM
    Cancer Discov; 2023 Jan; 13(1):216-243. PubMed ID: 36264161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TBL1XR1 Mutations Drive Extranodal Lymphoma by Inducing a Pro-tumorigenic Memory Fate.
    Venturutti L; Teater M; Zhai A; Chadburn A; Babiker L; Kim D; Béguelin W; Lee TC; Kim Y; Chin CR; Yewdell WT; Raught B; Phillip JM; Jiang Y; Staudt LM; Green MR; Chaudhuri J; Elemento O; Farinha P; Weng AP; Nissen MD; Steidl C; Morin RD; Scott DW; Privé GG; Melnick AM
    Cell; 2020 Jul; 182(2):297-316.e27. PubMed ID: 32619424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T(14;18)(q32;q21) involving MALT1 and IGH genes occurs in extranodal diffuse large B-cell lymphomas of the breast and testis.
    Kuper-Hommel MJ; Schreuder MI; Gemmink AH; van Krieken JH
    Mod Pathol; 2013 Mar; 26(3):421-7. PubMed ID: 23018871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diffuse large B-cell lymphoma: clinical implications of extranodal versus nodal presentation--a population-based study of 1575 cases.
    Møller MB; Pedersen NT; Christensen BE
    Br J Haematol; 2004 Jan; 124(2):151-9. PubMed ID: 14687024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The dangers of déjà vu: memory B cells as the cells of origin of ABC-DLBCLs.
    Venturutti L; Melnick AM
    Blood; 2020 Nov; 136(20):2263-2274. PubMed ID: 32932517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A reassessment of primary thyroid lymphoma: high-grade MALT-type lymphoma as a distinct subtype of diffuse large B-cell lymphoma.
    Skacel M; Ross CW; Hsi ED
    Histopathology; 2000 Jul; 37(1):10-8. PubMed ID: 10931213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of apoptosis and apoptosis-related gene products between extranodal oral B-cell lymphoma and maxillofacial nodal B-cell lymphoma.
    Yin H; Okada N; Takagi M
    J Oral Pathol Med; 2001 Mar; 30(3):141-7. PubMed ID: 11271628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The CREBBP Acetyltransferase Is a Haploinsufficient Tumor Suppressor in B-cell Lymphoma.
    Zhang J; Vlasevska S; Wells VA; Nataraj S; Holmes AB; Duval R; Meyer SN; Mo T; Basso K; Brindle PK; Hussein S; Dalla-Favera R; Pasqualucci L
    Cancer Discov; 2017 Mar; 7(3):322-337. PubMed ID: 28069569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sites of extranodal involvement are prognostic in patients with diffuse large B-cell lymphoma in the rituximab era: an analysis of the Surveillance, Epidemiology and End Results database.
    Castillo JJ; Winer ES; Olszewski AJ
    Am J Hematol; 2014 Mar; 89(3):310-4. PubMed ID: 24273125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical distinction of ABC and GCB in extranodal DLBCL is not reflected in mutation patterns.
    Hallas C; Preukschas M; Tiemann M
    Leuk Res; 2019 Jan; 76():107-111. PubMed ID: 30360939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clonal Evolution in Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System.
    Garcia-Reyero J; Martinez Magunacelaya N; Gonzalez Pereña A; Marcos Gonzalez S; Teran-Villagra N; Azueta A; Batlle A; Gonzalez de Villambrosia S; Revert Arce J; Montes-Moreno S
    Appl Immunohistochem Mol Morphol; 2020 Sep; 28(8):e68-e71. PubMed ID: 29629945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative population-based analysis of sinonasal diffuse large B-cell and extranodal NK/T-cell lymphomas.
    Dubal PM; Dutta R; Vazquez A; Patel TD; Baredes S; Eloy JA
    Laryngoscope; 2015 May; 125(5):1077-83. PubMed ID: 25546466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of clinical and immunophenotypic features along with treatment outcomes of diffuse large B cell lymphoma patients, based on the involvement of nodal or extranodal primary sites.
    Wang C; Li W; Liu C; He H; Bai O
    Blood Cells Mol Dis; 2016 Mar; 57():42-9. PubMed ID: 26852654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Most primary adrenal lymphomas are diffuse large B-cell lymphomas with non-germinal center B-cell phenotype, BCL6 gene rearrangement and poor prognosis.
    Mozos A; Ye H; Chuang WY; Chu JS; Huang WT; Chen HK; Hsu YH; Bacon CM; Du MQ; Campo E; Chuang SS
    Mod Pathol; 2009 Sep; 22(9):1210-7. PubMed ID: 19525926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diffuse large B-cell lymphoma and mantle cell lymphoma of the ocular adnexal region, and lymphoma of the lacrimal gland: an investigation of clinical and histopathological features.
    Rasmussen PK
    Acta Ophthalmol; 2013 Jul; 91 Thesis 5():1-27. PubMed ID: 24041159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MALT lymphoma and extranodal diffuse large B-cell lymphoma are targeted by aberrant somatic hypermutation.
    Deutsch AJ; Aigelsreiter A; Staber PB; Beham A; Linkesch W; Guelly C; Brezinschek RI; Fruhwirth M; Emberger W; Buettner M; Beham-Schmid C; Neumeister P
    Blood; 2007 Apr; 109(8):3500-4. PubMed ID: 17197434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B-cell lymphomas with concurrent IGH-BCL2 and MYC rearrangements are aggressive neoplasms with clinical and pathologic features distinct from Burkitt lymphoma and diffuse large B-cell lymphoma.
    Snuderl M; Kolman OK; Chen YB; Hsu JJ; Ackerman AM; Dal Cin P; Ferry JA; Harris NL; Hasserjian RP; Zukerberg LR; Abramson JS; Hochberg EP; Lee H; Lee AI; Toomey CE; Sohani AR
    Am J Surg Pathol; 2010 Mar; 34(3):327-40. PubMed ID: 20118770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical manifestation and treatment of extranodal diffuse large B-cell lymphoma].
    Tomita N
    Rinsho Ketsueki; 2016; 57(10):1991-1999. PubMed ID: 27725597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diffuse large B-cell lymphoma: clinical and biological characterization and outcome according to the nodal or extranodal primary origin.
    López-Guillermo A; Colomo L; Jiménez M; Bosch F; Villamor N; Arenillas L; Muntañola A; Montoto S; Giné E; Colomer D; Beà S; Campo E; Montserrat E
    J Clin Oncol; 2005 Apr; 23(12):2797-804. PubMed ID: 15728226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diffuse large B-cell lymphoma and red cell autoimmunity: clinical role and pathogenesis.
    Coombes C; Horikawa K; Jain S; Jiang S; Lim JH; Saxena K; Shadbolt B; Smyth L; Tobin J; Talaulikar D
    Pathology; 2023 Feb; 55(1):104-112. PubMed ID: 36420560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.